Amgen (AMGN)
(Delayed Data from NSDQ)
$321.66 USD
+0.33 (0.10%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $321.60 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for Amgen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 28,190 | 26,323 | 25,979 | 25,424 | 23,362 |
Cost Of Goods | 8,451 | 6,406 | 6,454 | 6,159 | 4,356 |
Gross Profit | 19,739 | 19,917 | 19,525 | 19,265 | 19,006 |
Selling & Adminstrative & Depr. & Amort Expenses | 11,842 | 10,351 | 11,886 | 10,126 | 9,332 |
Income After Depreciation & Amortization | 7,897 | 9,566 | 7,639 | 9,139 | 9,674 |
Non-Operating Income | 2,833 | -814 | 259 | 256 | 753 |
Interest Expense | 2,875 | 1,406 | 1,197 | 1,262 | 1,289 |
Pretax Income | 7,855 | 7,346 | 6,701 | 8,133 | 9,138 |
Income Taxes | 1,138 | 794 | 808 | 869 | 1,296 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 6,717 | 6,552 | 5,893 | 7,264 | 7,842 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 6,717 | 6,552 | 5,893 | 7,264 | 7,842 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11,968 | 12,983 | 11,037 | 12,740 | 11,880 |
Depreciation & Amortization (Cash Flow) | 4,071 | 3,417 | 3,398 | 3,601 | 2,206 |
Income After Depreciation & Amortization | 7,897 | 9,566 | 7,639 | 9,139 | 9,674 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 538.00 | 541.00 | 573.00 | 590.00 | 609.00 |
Diluted EPS Before Non-Recurring Items | 18.65 | 17.69 | 17.10 | 16.60 | 14.82 |
Diluted Net EPS (GAAP) | 12.49 | 12.11 | 10.28 | 12.31 | 12.88 |
Fiscal Year end for Amgen Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 8,388.00 | 7,447.00 | 8,196.00 | 6,903.00 |
Cost Of Goods | NA | 3,236.00 | 3,200.00 | 3,112.00 | 1,806.00 |
Gross Profit | NA | 5,152.00 | 4,247.00 | 5,084.00 | 5,097.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3,243.00 | 3,256.00 | 3,813.00 | 3,076.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,909.00 | 991.00 | 1,271.00 | 2,021.00 |
Non-Operating Income | NA | -307.00 | -235.00 | 402.00 | 685.00 |
Interest Expense | NA | 808.00 | 824.00 | 821.00 | 759.00 |
Pretax Income | NA | 794.00 | -68.00 | 852.00 | 1,947.00 |
Income Taxes | NA | 48.00 | 45.00 | 85.00 | 217.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 746.00 | -113.00 | 767.00 | 1,730.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 746.00 | -113.00 | 767.00 | 1,730.00 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 541.00 | 536.00 | 540.00 | 538.00 |
Diluted EPS Before Non-Recurring Items | NA | 4.97 | 3.96 | 4.71 | 4.96 |
Diluted Net EPS (GAAP) | NA | 1.38 | -0.21 | 1.42 | 3.22 |